Reported Standalone quarterly numbers for Kiran Vyapar are: Net Sales at Rs 36.08 crore in September 2024 up 429.13% from Rs. 6.82 crore in September 2023. Quarterly Net Profit at Rs. 25.29 crore in September 2024 up 801.8% from Rs. 2.80 crore in September 2023. EBITDA stands at Rs. 34.03 crore in September 2024 up 631.83% from Rs. 4.65 crore in September 2023.
Open FlipReported Standalone quarterly numbers for Ritesh International are: Net Sales at Rs 25.91 crore in September 2024 up 27.63% from Rs. 20.30 crore in September 2023. Quarterly Net Profit at Rs. 0.24 crore in September 2024 up 2804.82% from Rs. 0.01 crore in September 2023. EBITDA stands at Rs. 0.64 crore in September 2024 up 120.69% from Rs. 0.29 crore in September 2023.
Open FlipDr Reddys Laboratories Q2 Results : Dr Reddys Laboratories announced its Q2 results on November 5, 2024, revealing a mixed performance. The company’s topline saw a significant increase of 16.45% year-over-year, yet profit fell by 15.28%, indicating challenges in maintaining profitability despite higher revenues. In comparison to the previous quarter, revenue grew by 4.45%.
Open Flip